Ovarian cancer shuts down immune system cells that would otherwise act as a first line of defense against the deadly tumor, scientists report. But a therapy that restores the cells' disease-fighting abilities could provide a powerful new strategy to attack the cancer, which kills more than 14,000 women each year.